A PHP Error was encountered

Severity: Warning

Message: fopen(/var/cpanel/php/sessions/ea-php72/ci_session0ab8b1464578d1266a2372f403d17478d5551f3a): failed to open stream: No space left on device

Filename: drivers/Session_files_driver.php

Line Number: 176

Backtrace:

File: /home/rejovjcx/mraccuracyreports.com/application/controllers/Reportdetails.php
Line: 10
Function: library

File: /home/rejovjcx/mraccuracyreports.com/index.php
Line: 315
Function: require_once

A PHP Error was encountered

Severity: Warning

Message: session_start(): Failed to read session data: user (path: /var/cpanel/php/sessions/ea-php72)

Filename: Session/Session.php

Line Number: 143

Backtrace:

File: /home/rejovjcx/mraccuracyreports.com/application/controllers/Reportdetails.php
Line: 10
Function: library

File: /home/rejovjcx/mraccuracyreports.com/index.php
Line: 315
Function: require_once

Global Targeted-protein Degradation Therapeutics Market Insights, Forecast to 2034

img

Global Targeted-protein Degradation Therapeutics Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Targeted-protein Degradation Therapeutics Market Insights, Forecast to 2034

Targeted protein degradation (TPD) has surfaced as a novel and innovative chemical tool and therapeutic modality. By co-opting protein degradation pathways, TPD facilitates complete removal of the protein molecules from within or outside the cell. While the pioneering Proteolysis-Targeting Chimera (PROTAC) technology and molecular glues hijack the ubiquitin-proteasome system, newer modalities co-opt autophagy or the endo-lysosomal pathway.
Market Analysis and InsightsGlobal Targeted-protein Degradation Therapeutics Market
Global Targeted-protein Degradation Therapeutics market is expected to reach to US$ 1266 million in 2023, with a positive growth of %, compared with US$ 1132 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Targeted-protein Degradation Therapeutics industry is evaluated to reach US$ 1821.4 million in 2033. The CAGR will be 6.3% during 2023 to 2033.
The Protein Degradation Therapy market has gained momentum as a promising approach in drug development. This innovative strategy aims to target disease-causing proteins by facilitating their degradation within cells. Proteins that contribute to diseases like cancer and neurodegenerative disorders can be selectively broken down using small molecules known as proteolysis-targeting chimeras (PROTACs) or other protein degraders. This approach offers advantages over traditional inhibition methods, potentially leading to more effective treatments with reduced side effects. As researchers delve into protein-protein interactions and cellular mechanisms, the Protein Degradation Therapy market is expanding, presenting opportunities to address previously challenging diseases and advance precision medicine. Clinical progress and continued research in this field are expected to shape the future of therapeutic interventions.
Report Covers
This report presents an overview of global Targeted-protein Degradation Therapeutics market from 2018 to 2033, aiming to help readers to get a comprehensive understanding of global Targeted-protein Degradation Therapeutics market with multiple angles. Items like regional revenue from 2018 to 2033 and companies’ revenue and gross margin from 2018 to 2023 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2033 are also highlighted.
Companies, Type, Application and Regions Listed in the Report



By Company


Arvinas
Nurix Therapeutics
Kymera Therapeutics
C4 Therapeutics
Segment by Type
ARV-110
ARV-471
Other

Segment by Application


Cancer
Neuroscience
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2033
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2033 globally
Chapter 5Product revenue analysis by application from 2018 to 2033 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2033 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2033
Chapter 7Product revenue analysis by type and application from 2018 to 2033 in Europe. Product revenue analysis of each country in Europe from 2018 to 2033
Chapter 8Product revenue analysis by type and application from 2018 to 2033 in China. Product revenue analysis of China from 2018 to 2033
Chapter 9Product revenue analysis by type and application from 2018 to 2033 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2033
Chapter 10Product revenue analysis by type and application from 2018 to 2033 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2033.
Chapter 11Companies’ outline, covering company’s basic information, major business, Targeted-protein Degradation Therapeutics introduction, etc. Targeted-protein Degradation Therapeutics Revenue and Gross Margin of each company from 2018 to 2023
Chapter 12MRAResearch’s Conclusions of Targeted-protein Degradation Therapeutics
Chapter 13Methodology and Data Sources adopted by MRAResearch

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Targeted-protein Degradation Therapeutics Market Size Growth Rate by Type, 2018 VS 2022 VS 2033
1.2.2 ARV-110
1.2.3 ARV-471
1.2.4 Other
1.3 Market by Application
1.3.1 Global Targeted-protein Degradation Therapeutics Market Size Growth Rate by Application, 2018 VS 2022 VS 2033
1.3.2 Cancer
1.3.3 Neuroscience
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Targeted-protein Degradation Therapeutics Market Perspective (2018-2033)
2.2 Global Targeted-protein Degradation Therapeutics Growth Trends by Region
2.2.1 Targeted-protein Degradation Therapeutics Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Targeted-protein Degradation Therapeutics Historic Market Size by Region (2018-2023)
2.2.3 Targeted-protein Degradation Therapeutics Forecasted Market Size by Region (2024-2033)
2.3 Targeted-protein Degradation Therapeutics Market Dynamics
2.3.1 Targeted-protein Degradation Therapeutics Industry Trends
2.3.2 Targeted-protein Degradation Therapeutics Market Drivers
2.3.3 Targeted-protein Degradation Therapeutics Market Challenges
2.3.4 Targeted-protein Degradation Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Targeted-protein Degradation Therapeutics by Players
3.1.1 Global Targeted-protein Degradation Therapeutics Revenue by Players (2018-2023)
3.1.2 Global Targeted-protein Degradation Therapeutics Revenue Market Share by Players (2018-2023)
3.2 Global Targeted-protein Degradation Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Targeted-protein Degradation Therapeutics, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Targeted-protein Degradation Therapeutics Market Concentration Ratio
3.4.1 Global Targeted-protein Degradation Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Targeted-protein Degradation Therapeutics Revenue in 2022
3.5 Global Key Players of Targeted-protein Degradation Therapeutics Head office and Area Served
3.6 Global Key Players of Targeted-protein Degradation Therapeutics, Product and Application
3.7 Global Key Players of Targeted-protein Degradation Therapeutics, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Targeted-protein Degradation Therapeutics Breakdown Data by Type
4.1 Global Targeted-protein Degradation Therapeutics Historic Market Size by Type (2018-2023)
4.2 Global Targeted-protein Degradation Therapeutics Forecasted Market Size by Type (2024-2033)
5 Targeted-protein Degradation Therapeutics Breakdown Data by Application
5.1 Global Targeted-protein Degradation Therapeutics Historic Market Size by Application (2018-2023)
5.2 Global Targeted-protein Degradation Therapeutics Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Targeted-protein Degradation Therapeutics Market Size (2018-2033)
6.2 North America Targeted-protein Degradation Therapeutics Market Size by Type
6.2.1 North America Targeted-protein Degradation Therapeutics Market Size by Type (2018-2023)
6.2.2 North America Targeted-protein Degradation Therapeutics Market Size by Type (2024-2033)
6.2.3 North America Targeted-protein Degradation Therapeutics Market Share by Type (2018-2033)
6.3 North America Targeted-protein Degradation Therapeutics Market Size by Application
6.3.1 North America Targeted-protein Degradation Therapeutics Market Size by Application (2018-2023)
6.3.2 North America Targeted-protein Degradation Therapeutics Market Size by Application (2024-2033)
6.3.3 North America Targeted-protein Degradation Therapeutics Market Share by Application (2018-2033)
6.4 North America Targeted-protein Degradation Therapeutics Market Size by Country
6.4.1 North America Targeted-protein Degradation Therapeutics Market Size by Country: 2018 VS 2022 VS 2033
6.4.2 North America Targeted-protein Degradation Therapeutics Market Size by Country (2018-2023)
6.4.3 North America Targeted-protein Degradation Therapeutics Market Size by Country (2024-2033)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Targeted-protein Degradation Therapeutics Market Size (2018-2033)
7.2 Europe Targeted-protein Degradation Therapeutics Market Size by Type
7.2.1 Europe Targeted-protein Degradation Therapeutics Market Size by Type (2018-2023)
7.2.2 Europe Targeted-protein Degradation Therapeutics Market Size by Type (2024-2033)
7.2.3 Europe Targeted-protein Degradation Therapeutics Market Share by Type (2018-2033)
7.3 Europe Targeted-protein Degradation Therapeutics Market Size by Application
7.3.1 Europe Targeted-protein Degradation Therapeutics Market Size by Application (2018-2023)
7.3.2 Europe Targeted-protein Degradation Therapeutics Market Size by Application (2024-2033)
7.3.3 Europe Targeted-protein Degradation Therapeutics Market Share by Application (2018-2033)
7.4 Europe Targeted-protein Degradation Therapeutics Market Size by Country
7.4.1 Europe Targeted-protein Degradation Therapeutics Market Size by Country: 2018 VS 2022 VS 2033
7.4.2 Europe Targeted-protein Degradation Therapeutics Market Size by Country (2018-2023)
7.4.3 Europe Targeted-protein Degradation Therapeutics Market Size by Country (2024-2033)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Targeted-protein Degradation Therapeutics Market Size (2018-2033)
8.2 China Targeted-protein Degradation Therapeutics Market Size by Type
8.2.1 China Targeted-protein Degradation Therapeutics Market Size by Type (2018-2023)
8.2.2 China Targeted-protein Degradation Therapeutics Market Size by Type (2024-2033)
8.2.3 China Targeted-protein Degradation Therapeutics Market Share by Type (2018-2033)
8.3 China Targeted-protein Degradation Therapeutics Market Size by Application
8.3.1 China Targeted-protein Degradation Therapeutics Market Size by Application (2018-2023)
8.3.2 China Targeted-protein Degradation Therapeutics Market Size by Application (2024-2033)
8.3.3 China Targeted-protein Degradation Therapeutics Market Share by Application (2018-2033)
9 Asia (excluding China)
9.1 Asia Targeted-protein Degradation Therapeutics Market Size (2018-2033)
9.2 Asia Targeted-protein Degradation Therapeutics Market Size by Type
9.2.1 Asia Targeted-protein Degradation Therapeutics Market Size by Type (2018-2023)
9.2.2 Asia Targeted-protein Degradation Therapeutics Market Size by Type (2024-2033)
9.2.3 Asia Targeted-protein Degradation Therapeutics Market Share by Type (2018-2033)
9.3 Asia Targeted-protein Degradation Therapeutics Market Size by Application
9.3.1 Asia Targeted-protein Degradation Therapeutics Market Size by Application (2018-2023)
9.3.2 Asia Targeted-protein Degradation Therapeutics Market Size by Application (2024-2033)
9.3.3 Asia Targeted-protein Degradation Therapeutics Market Share by Application (2018-2033)
9.4 Asia Targeted-protein Degradation Therapeutics Market Size by Region
9.4.1 Asia Targeted-protein Degradation Therapeutics Market Size by Region: 2018 VS 2022 VS 2033
9.4.2 Asia Targeted-protein Degradation Therapeutics Market Size by Region (2018-2023)
9.4.3 Asia Targeted-protein Degradation Therapeutics Market Size by Region (2024-2033)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Targeted-protein Degradation Therapeutics Market Size (2018-2033)
10.2 Middle East, Africa, and Latin America Targeted-protein Degradation Therapeutics Market Size by Type
10.2.1 Middle East, Africa, and Latin America Targeted-protein Degradation Therapeutics Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Targeted-protein Degradation Therapeutics Market Size by Type (2024-2033)
10.2.3 Middle East, Africa, and Latin America Targeted-protein Degradation Therapeutics Market Share by Type (2018-2033)
10.3 Middle East, Africa, and Latin America Targeted-protein Degradation Therapeutics Market Size by Application
10.3.1 Middle East, Africa, and Latin America Targeted-protein Degradation Therapeutics Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Targeted-protein Degradation Therapeutics Market Size by Application (2024-2033)
10.3.3 Middle East, Africa, and Latin America Targeted-protein Degradation Therapeutics Market Share by Application (2018-2033)
10.4 Middle East, Africa, and Latin America Targeted-protein Degradation Therapeutics Market Size by Country
10.4.1 Middle East, Africa, and Latin America Targeted-protein Degradation Therapeutics Market Size by Country: 2018 VS 2022 VS 2033
10.4.2 Middle East, Africa, and Latin America Targeted-protein Degradation Therapeutics Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Targeted-protein Degradation Therapeutics Market Size by Country (2024-2033)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Arvinas
11.1.1 Arvinas Company Details
11.1.2 Arvinas Business Overview
11.1.3 Arvinas Targeted-protein Degradation Therapeutics Introduction
11.1.4 Arvinas Revenue in Targeted-protein Degradation Therapeutics Business (2018-2023)
11.1.5 Arvinas Recent Developments
11.2 Nurix Therapeutics
11.2.1 Nurix Therapeutics Company Details
11.2.2 Nurix Therapeutics Business Overview
11.2.3 Nurix Therapeutics Targeted-protein Degradation Therapeutics Introduction
11.2.4 Nurix Therapeutics Revenue in Targeted-protein Degradation Therapeutics Business (2018-2023)
11.2.5 Nurix Therapeutics Recent Developments
11.3 Kymera Therapeutics
11.3.1 Kymera Therapeutics Company Details
11.3.2 Kymera Therapeutics Business Overview
11.3.3 Kymera Therapeutics Targeted-protein Degradation Therapeutics Introduction
11.3.4 Kymera Therapeutics Revenue in Targeted-protein Degradation Therapeutics Business (2018-2023)
11.3.5 Kymera Therapeutics Recent Developments
11.4 C4 Therapeutics
11.4.1 C4 Therapeutics Company Details
11.4.2 C4 Therapeutics Business Overview
11.4.3 C4 Therapeutics Targeted-protein Degradation Therapeutics Introduction
11.4.4 C4 Therapeutics Revenue in Targeted-protein Degradation Therapeutics Business (2018-2023)
11.4.5 C4 Therapeutics Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Targeted-protein Degradation Therapeutics Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2033
Table 2. Key Players of ARV-110
Table 3. Key Players of ARV-471
Table 4. Key Players of Other
Table 5. Global Targeted-protein Degradation Therapeutics Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2033
Table 6. Global Targeted-protein Degradation Therapeutics Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 7. Global Targeted-protein Degradation Therapeutics Market Size by Region (2018-2023) & (US$ Million)
Table 8. Global Targeted-protein Degradation Therapeutics Market Share by Region (2018-2023)
Table 9. Global Targeted-protein Degradation Therapeutics Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 10. Global Targeted-protein Degradation Therapeutics Market Share by Region (2024-2033)
Table 11. Targeted-protein Degradation Therapeutics Market Trends
Table 12. Targeted-protein Degradation Therapeutics Market Drivers
Table 13. Targeted-protein Degradation Therapeutics Market Challenges
Table 14. Targeted-protein Degradation Therapeutics Market Restraints
Table 15. Global Targeted-protein Degradation Therapeutics Revenue by Players (2018-2023) & (US$ Million)
Table 16. Global Targeted-protein Degradation Therapeutics Revenue Share by Players (2018-2023)
Table 17. Global Top Targeted-protein Degradation Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Targeted-protein Degradation Therapeutics as of 2022)
Table 18. Global Targeted-protein Degradation Therapeutics Industry Ranking 2021 VS 2022 VS 2023
Table 19. Global 5 Largest Players Market Share by Targeted-protein Degradation Therapeutics Revenue (CR5 and HHI) & (2018-2023)
Table 20. Global Key Players of Targeted-protein Degradation Therapeutics, Headquarters and Area Served
Table 21. Global Key Players of Targeted-protein Degradation Therapeutics, Product and Application
Table 22. Global Key Players of Targeted-protein Degradation Therapeutics, Product and Application
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Targeted-protein Degradation Therapeutics Market Size by Type (2018-2023) & (US$ Million)
Table 25. Global Targeted-protein Degradation Therapeutics Revenue Market Share by Type (2018-2023)
Table 26. Global Targeted-protein Degradation Therapeutics Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 27. Global Targeted-protein Degradation Therapeutics Revenue Market Share by Type (2024-2033)
Table 28. Global Targeted-protein Degradation Therapeutics Market Size by Application (2018-2023) & (US$ Million)
Table 29. Global Targeted-protein Degradation Therapeutics Revenue Share by Application (2018-2023)
Table 30. Global Targeted-protein Degradation Therapeutics Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 31. Global Targeted-protein Degradation Therapeutics Revenue Share by Application (2024-2033)
Table 32. North America Targeted-protein Degradation Therapeutics Market Size by Type (2018-2023) & (US$ Million)
Table 33. North America Targeted-protein Degradation Therapeutics Market Size by Type (2024-2033) & (US$ Million)
Table 34. North America Targeted-protein Degradation Therapeutics Market Size by Application (2018-2023) & (US$ Million)
Table 35. North America Targeted-protein Degradation Therapeutics Market Size by Application (2024-2033) & (US$ Million)
Table 36. North America Targeted-protein Degradation Therapeutics Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 37. North America Targeted-protein Degradation Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 38. North America Targeted-protein Degradation Therapeutics Market Size by Country (2024-2033) & (US$ Million)
Table 39. Europe Targeted-protein Degradation Therapeutics Market Size by Type (2018-2023) & (US$ Million)
Table 40. Europe Targeted-protein Degradation Therapeutics Market Size by Type (2024-2033) & (US$ Million)
Table 41. Europe Targeted-protein Degradation Therapeutics Market Size by Application (2018-2023) & (US$ Million)
Table 42. Europe Targeted-protein Degradation Therapeutics Market Size by Application (2024-2033) & (US$ Million)
Table 43. Europe Targeted-protein Degradation Therapeutics Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 44. Europe Targeted-protein Degradation Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 45. Europe Targeted-protein Degradation Therapeutics Market Size by Country (2024-2033) & (US$ Million)
Table 46. China Targeted-protein Degradation Therapeutics Market Size by Type (2018-2023) & (US$ Million)
Table 47. China Targeted-protein Degradation Therapeutics Market Size by Type (2024-2033) & (US$ Million)
Table 48. China Targeted-protein Degradation Therapeutics Market Size by Application (2018-2023) & (US$ Million)
Table 49. China Targeted-protein Degradation Therapeutics Market Size by Application (2024-2033) & (US$ Million)
Table 50. Asia Targeted-protein Degradation Therapeutics Market Size by Type (2018-2023) & (US$ Million)
Table 51. Asia Targeted-protein Degradation Therapeutics Market Size by Type (2024-2033) & (US$ Million)
Table 52. Asia Targeted-protein Degradation Therapeutics Market Size by Application (2018-2023) & (US$ Million)
Table 53. Asia Targeted-protein Degradation Therapeutics Market Size by Application (2024-2033) & (US$ Million)
Table 54. Asia Targeted-protein Degradation Therapeutics Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 55. Asia Targeted-protein Degradation Therapeutics Market Size by Region (2018-2023) & (US$ Million)
Table 56. Asia Targeted-protein Degradation Therapeutics Market Size by Region (2024-2033) & (US$ Million)
Table 57. Middle East, Africa, and Latin America Targeted-protein Degradation Therapeutics Market Size by Type (2018-2023) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Targeted-protein Degradation Therapeutics Market Size by Type (2024-2033) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Targeted-protein Degradation Therapeutics Market Size by Application (2018-2023) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Targeted-protein Degradation Therapeutics Market Size by Application (2024-2033) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Targeted-protein Degradation Therapeutics Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 62. Middle East, Africa, and Latin America Targeted-protein Degradation Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 63. Middle East, Africa, and Latin America Targeted-protein Degradation Therapeutics Market Size by Country (2024-2033) & (US$ Million)
Table 64. Arvinas Company Details
Table 65. Arvinas Business Overview
Table 66. Arvinas Targeted-protein Degradation Therapeutics Product
Table 67. Arvinas Revenue in Targeted-protein Degradation Therapeutics Business (2018-2023) & (US$ Million)
Table 68. Arvinas Recent Developments
Table 69. Nurix Therapeutics Company Details
Table 70. Nurix Therapeutics Business Overview
Table 71. Nurix Therapeutics Targeted-protein Degradation Therapeutics Product
Table 72. Nurix Therapeutics Revenue in Targeted-protein Degradation Therapeutics Business (2018-2023) & (US$ Million)
Table 73. Nurix Therapeutics Recent Developments
Table 74. Kymera Therapeutics Company Details
Table 75. Kymera Therapeutics Business Overview
Table 76. Kymera Therapeutics Targeted-protein Degradation Therapeutics Product
Table 77. Kymera Therapeutics Revenue in Targeted-protein Degradation Therapeutics Business (2018-2023) & (US$ Million)
Table 78. Kymera Therapeutics Recent Developments
Table 79. C4 Therapeutics Company Details
Table 80. C4 Therapeutics Business Overview
Table 81. C4 Therapeutics Targeted-protein Degradation Therapeutics Product
Table 82. C4 Therapeutics Revenue in Targeted-protein Degradation Therapeutics Business (2018-2023) & (US$ Million)
Table 83. C4 Therapeutics Recent Developments
Table 84. Research Programs/Design for This Report
Table 85. Key Data Information from Secondary Sources
Table 86. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Targeted-protein Degradation Therapeutics Market Size Growth Rate by Type, 2018 VS 2022 VS 2033 (US$ Million)
Figure 2. Global Targeted-protein Degradation Therapeutics Market Share by Type: 2022 VS 2033
Figure 3. ARV-110 Features
Figure 4. ARV-471 Features
Figure 5. Other Features
Figure 6. Global Targeted-protein Degradation Therapeutics Market Size Growth Rate by Application, 2018 VS 2022 VS 2033 (US$ Million)
Figure 7. Global Targeted-protein Degradation Therapeutics Market Share by Application: 2022 VS 2033
Figure 8. Cancer Case Studies
Figure 9. Neuroscience Case Studies
Figure 10. Other Case Studies
Figure 11. Targeted-protein Degradation Therapeutics Report Years Considered
Figure 12. Global Targeted-protein Degradation Therapeutics Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 13. Global Targeted-protein Degradation Therapeutics Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 14. Global Targeted-protein Degradation Therapeutics Market Share by Region: 2022 VS 2033
Figure 15. Global Targeted-protein Degradation Therapeutics Market Share by Players in 2022
Figure 16. Global Top Targeted-protein Degradation Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Targeted-protein Degradation Therapeutics as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by Targeted-protein Degradation Therapeutics Revenue in 2022
Figure 18. North America Targeted-protein Degradation Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 19. North America Targeted-protein Degradation Therapeutics Market Share by Type (2018-2033)
Figure 20. North America Targeted-protein Degradation Therapeutics Market Share by Application (2018-2033)
Figure 21. North America Targeted-protein Degradation Therapeutics Market Share by Country (2018-2033)
Figure 22. United States Targeted-protein Degradation Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Canada Targeted-protein Degradation Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. Europe Targeted-protein Degradation Therapeutics Market Size YoY (2018-2033) & (US$ Million)
Figure 25. Europe Targeted-protein Degradation Therapeutics Market Share by Type (2018-2033)
Figure 26. Europe Targeted-protein Degradation Therapeutics Market Share by Application (2018-2033)
Figure 27. Europe Targeted-protein Degradation Therapeutics Market Share by Country (2018-2033)
Figure 28. Germany Targeted-protein Degradation Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. France Targeted-protein Degradation Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. U.K. Targeted-protein Degradation Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Italy Targeted-protein Degradation Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Russia Targeted-protein Degradation Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Nordic Countries Targeted-protein Degradation Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. China Targeted-protein Degradation Therapeutics Market Size YoY (2018-2033) & (US$ Million)
Figure 35. China Targeted-protein Degradation Therapeutics Market Share by Type (2018-2033)
Figure 36. China Targeted-protein Degradation Therapeutics Market Share by Application (2018-2033)
Figure 37. Asia Targeted-protein Degradation Therapeutics Market Size YoY (2018-2033) & (US$ Million)
Figure 38. Asia Targeted-protein Degradation Therapeutics Market Share by Type (2018-2033)
Figure 39. Asia Targeted-protein Degradation Therapeutics Market Share by Application (2018-2033)
Figure 40. Asia Targeted-protein Degradation Therapeutics Market Share by Region (2018-2033)
Figure 41. Japan Targeted-protein Degradation Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. South Korea Targeted-protein Degradation Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. China Taiwan Targeted-protein Degradation Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Southeast Asia Targeted-protein Degradation Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. India Targeted-protein Degradation Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Australia Targeted-protein Degradation Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. Middle East, Africa, and Latin America Targeted-protein Degradation Therapeutics Market Size YoY (2018-2033) & (US$ Million)
Figure 48. Middle East, Africa, and Latin America Targeted-protein Degradation Therapeutics Market Share by Type (2018-2033)
Figure 49. Middle East, Africa, and Latin America Targeted-protein Degradation Therapeutics Market Share by Application (2018-2033)
Figure 50. Middle East, Africa, and Latin America Targeted-protein Degradation Therapeutics Market Share by Country (2018-2033)
Figure 51. Brazil Targeted-protein Degradation Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 52. Mexico Targeted-protein Degradation Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 53. Turkey Targeted-protein Degradation Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 54. Saudi Arabia Targeted-protein Degradation Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 55. Israel Targeted-protein Degradation Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 56. GCC Countries Targeted-protein Degradation Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 57. Arvinas Revenue Growth Rate in Targeted-protein Degradation Therapeutics Business (2018-2023)
Figure 58. Nurix Therapeutics Revenue Growth Rate in Targeted-protein Degradation Therapeutics Business (2018-2023)
Figure 59. Kymera Therapeutics Revenue Growth Rate in Targeted-protein Degradation Therapeutics Business (2018-2023)
Figure 60. C4 Therapeutics Revenue Growth Rate in Targeted-protein Degradation Therapeutics Business (2018-2023)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries